|
|
Volumn 64, Issue SUPPL. 166, 2010, Pages 29-40
|
|
New ways of insulin delivery: Advanced technologies and treatments for diabetes
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFRESA;
AIR INHALED INSULIN;
GLUCOSE;
HEMOGLOBIN A1C;
INSULIN;
INSULIN ANTIBODY;
INSULIN DERIVATIVE;
INSULIN LISPRO;
NASULIN;
ORAL ANTIDIABETIC AGENT;
RECOMBINANT HUMAN INSULIN;
SALBUTAMOL;
TECHNOSPHERE INSULIN;
UNCLASSIFIED DRUG;
ASTHMA;
BODY MASS;
CLINICAL TRIAL;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG DELIVERY SYSTEM;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG POTENCY;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
ECONOMIC ASPECT;
EUROPE;
EXERCISE;
FEEDING BEHAVIOR;
FORCED EXPIRATORY VOLUME;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
IMMUNE RESPONSE;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN TREATMENT;
LUNG CANCER;
LUNG FUNCTION;
LUNG FUNCTION TEST;
MARKET;
MEDICAL SPECIALIST;
NICOTINE REPLACEMENT THERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
NOTE;
OXIDATIVE STRESS;
PARALLEL DESIGN;
PASSIVE SMOKING;
PRIORITY JOURNAL;
PSYCHOLOGICAL ASPECT;
SMOKING;
SMOKING CESSATION;
UNITED STATES;
|
|
EID: 76749136339
PISSN: 13685031
EISSN: 17421241
Source Type: Journal
DOI: 10.1111/j.1742-1241.2009.02276.x Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|
